Skip to main content
Premium Trial:

Request an Annual Quote

BCW Index Drops Slightly in Short Trading Week

The BCW Index returned after skipping a week due to the Thanksgiving holiday with a .3-percent decline. The tracking period included four days of trading rather than the usual five days due to the holiday. Harvard Bioscience led gainers during the week with a 5.2-percent increase, while Waters led decliners with a 2.2-percent drop.

In comparison, the Dow Jones Industrial Average posted a meager gain of .2 percent for the week, while the Nasdaq fell .9 percent, and the Nasdaq Biotech Index dropped 4 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(Nov. 29, 2005)
Last Price
(Nov. 22, 2005)
% change
Agilent
A
35.49
35.57
-0.22
Applied Biosystems
ABI
27.35
27.39
-0.15
Beckman
BEC
55.63
56.45
-1.45
Bio-Rad
BIO
58.43
59.45
-1.72
Bruker
BRKR
4.8
4.79
0.21
Fisher Scientific
FSH
64.16
63.4
1.20
GE
GE
35.93
36.06
-0.36
Harvard Bio
HBIO
3.66
3.48
5.17
Invitrogen
IVGN
64.5
64
0.78
Molecular Devices
MDCC
26.17
26.26
-0.34
PerkinElmer
PKI
22.73
22.71
0.09
Qiagen
QGEN
11.17
11.32
-1.33
Sigma
SIAL
66.06
66.59
-0.80
Stratagene
STGN
10.15
10.17
-0.20
Thermo
TMO
30.74
30.29
1.49
Waters
WAT
39.62
40.5
-2.17
BCW Index Average
34.79
34.90
-0.33
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.